Zobrazeno 1 - 3
of 3
pro vyhledávání: '"D. D. Grigoreva"'
Autor:
E. M. Zhidkova, V. P. Maksimova, D. D. Grigoreva, V. Z. Shirinian, M. G. Yakubovskaya, E. A. Lesovaya
Publikováno v:
Успехи молекулярной онкологии, Vol 11, Iss 3, Pp 92-102 (2024)
Introduction. Glucocorticoids (GC) are widely used in breast cancer (BC) therapy to reduce the side effects of cytostatic drugs and may exhibit antiproliferative effects on luminal BC cells. The biological action of GC is mediated by glucocorticoid r
Externí odkaz:
https://doaj.org/article/aeda34579f534e2d8ea0b82aace458ea
Autor:
E. M. Zhidkova, D. D. Grigoreva, E. S. Lylova, V. P. Maksimova, G. R. Sagitova, G. I. Khayrieva, E. S. Trapeznikova, K. I. Kirsanov, M. G. Yakubovskaya, E. A. Lesovaya
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 3, Pp 50-60 (2022)
Objective: screening of previously selected DDIT4 inhibitors by their ability to suppress basal and glucocorticoid-induced expression of this gene in breast cancer (BC) cells, as well as evaluation of antiproliferative and cytotoxic effects of the st
Externí odkaz:
https://doaj.org/article/0a86cb5f69c84ab6be5b86b5ee7b8015
Autor:
D. D. Grigoreva, E. M. Zhidkova, E. S. Lylova, A. D. Enikeev, K. I. Kirsanov, G. A. Belitsky, M. G. Yakubovskaya, E. A. Lesovaya
Publikováno v:
Успехи молекулярной онкологии, Vol 9, Iss 4 (2022)
Introduction. Current chemotherapy of breast cancer has a wide range of disadvantages, in particular, the development of therapy-related infections and hormonal imbalance. Combination of main cytostatic with glucocorticoids allows to broaden its ther
Externí odkaz:
https://doaj.org/article/0fd1933c86234903a378d022060954b1